Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adefovir Dipivoxil PK in Pediatric Chronic Hepatitis B
NCT00645294Phase 2Completed
- Sponsor
- Gilead Sciences
- Start
- Feb 2003
- Primary completion
- Aug 2003
- Modality
- Small Molecules
- Countries
- 4
01
Overview
Phase 2, randomised, open-label trial of adefovir dipivoxil in Chronic Hepatitis B (CHB) (3 arms), sponsored by Gilead Sciences. Primary endpoint: Pharmacokinetic profile at 8 days. Started Feb 2003; status: completed.
02
Drugs
adefovir dipivoxil
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT00645294.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00645294.